• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清抗苗勒管激素测定在多囊卵巢综合征诊断中的应用。

Utility of Serum Anti-Müllerian Hormone Measurement as Part of Polycystic Ovary Syndrome Diagnosis.

机构信息

Department of Obstetrics and Gynecology, Research Unit of Clinical Medicine, Medical Research Center Oulu, University of Oulu, Oulu University Hospital, Oulu, Finland.

Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.

出版信息

Semin Reprod Med. 2024 Mar;42(1):49-59. doi: 10.1055/s-0044-1786731. Epub 2024 May 22.

DOI:10.1055/s-0044-1786731
PMID:38776986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11257749/
Abstract

The 2023 international evidence-based guideline update for the assessment and management of polycystic ovary syndrome (PCOS) recommends using the Rotterdam criteria for the diagnosis of PCOS. The updated guideline has evidence-based recommendation for the diagnosis, and it now also includes serum anti-Müllerian hormone (AMH) measurement as an alternative tool for gynecological ultrasound to diagnose polycystic ovary morphology (PCOM). The aim of this new recommendation was to facilitate PCOS diagnostic workup in primary care and other disciplines, as currently most diagnosing is done in gynecology and infertility clinics. Here, we review factors affecting AMH levels as well as the utility of AMH in PCOS diagnosis. We identified relevant studies that report different cut-offs for AMH to diagnose PCOM as part of PCOS diagnosis. There are, however, some limitations when using AMH that should be acknowledged. These include physiological aspects like age, ethnicity, and obesity and iatrogenic causes like hormonal medication and ovarian surgery. Also reference ranges are different depending on AMH assay used. As a summary, we conclude that AMH is a usable tool in PCOM diagnostics, but it does not have a single cut-off. Therefore, further studies are needed to establish age and assay-based reference ranges.

摘要

2023 年国际多囊卵巢综合征(PCOS)评估和管理循证指南更新建议使用鹿特丹标准诊断 PCOS。该更新指南为诊断提供了循证推荐,现在还包括血清抗苗勒管激素(AMH)测量作为妇科超声诊断多囊卵巢形态(PCOM)的替代工具。这一建议的目的是为了促进初级保健和其他学科的 PCOS 诊断工作,因为目前大多数诊断都是在妇科和不孕不育诊所进行的。在这里,我们回顾了影响 AMH 水平的因素,以及 AMH 在 PCOS 诊断中的应用。我们确定了一些相关研究,这些研究报告了不同的 AMH 截断值用于诊断 PCOM,作为 PCOS 诊断的一部分。然而,在使用 AMH 时存在一些需要注意的局限性。这些局限性包括生理方面,如年龄、种族和肥胖,以及医源性因素,如激素药物和卵巢手术。此外,参考范围还取决于所使用的 AMH 检测方法。总的来说,我们得出结论,AMH 是 PCOM 诊断中可用的工具,但它没有单一的截断值。因此,需要进一步的研究来建立基于年龄和检测方法的参考范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1d/11257749/dc91bad4e477/10-1055-s-0044-1786731-i2400008-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1d/11257749/dc91bad4e477/10-1055-s-0044-1786731-i2400008-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1d/11257749/dc91bad4e477/10-1055-s-0044-1786731-i2400008-1.jpg

相似文献

1
Utility of Serum Anti-Müllerian Hormone Measurement as Part of Polycystic Ovary Syndrome Diagnosis.血清抗苗勒管激素测定在多囊卵巢综合征诊断中的应用。
Semin Reprod Med. 2024 Mar;42(1):49-59. doi: 10.1055/s-0044-1786731. Epub 2024 May 22.
2
Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.多囊卵巢形态学与多囊卵巢综合征的诊断:应用聚类分析重新定义卵泡计数和血清抗苗勒管激素的临界值。
Hum Reprod. 2017 Aug 1;32(8):1723-1731. doi: 10.1093/humrep/dex226.
3
Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.以血清抗苗勒管激素替代多囊卵巢形态学诊断标准可增加多囊卵巢综合征的诊断人数:一项基于社区的横断面研究。
Hum Reprod. 2021 Dec 27;37(1):109-118. doi: 10.1093/humrep/deab232.
4
Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.将血清抗苗勒管激素检测作为多囊卵巢形态的替代指标:对多囊卵巢综合征的诊断和表型分类的影响。
Hum Reprod. 2017 Aug 1;32(8):1716-1722. doi: 10.1093/humrep/dex239.
5
Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis.抗缪勒管激素作为多囊卵巢综合征和多囊卵巢形态的诊断生物标志物:系统评价和荟萃分析。
Fertil Steril. 2024 Oct;122(4):727-739. doi: 10.1016/j.fertnstert.2024.05.163. Epub 2024 Jun 27.
6
AMH as part of the diagnostic PCOS workup in large epidemiological studies.抗缪勒管激素(AMH)作为大型流行病学研究中多囊卵巢综合征(PCOS)诊断检查的一部分。
Eur J Endocrinol. 2023 Jun 7;188(6):547-554. doi: 10.1093/ejendo/lvad065.
7
Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.在月经周期规律的非高雄激素血症女性群体中,使用聚类分析来识别具有多囊卵巢形态的同质亚组女性。
Hum Reprod. 2014 Nov;29(11):2536-43. doi: 10.1093/humrep/deu242. Epub 2014 Sep 29.
8
Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.通过抗苗勒管激素临界值鉴别多囊卵巢综合征和多囊卵巢形态。
Korean J Intern Med. 2017 Jul;32(4):690-698. doi: 10.3904/kjim.2016.038. Epub 2016 Nov 30.
9
Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?抗苗勒管激素在多囊卵巢综合征诊断中的价值:形态学描述能否被取代?
Hum Reprod. 2012 Aug;27(8):2494-502. doi: 10.1093/humrep/des213. Epub 2012 Jun 12.
10
Antimüllerian hormone to determine polycystic ovarian morphology.抗苗勒管激素用于判断多囊卵巢形态。
Fertil Steril. 2021 Oct;116(4):1149-1157. doi: 10.1016/j.fertnstert.2021.05.094.

引用本文的文献

1
Bibliometric analysis of the research on anti-Müllerian hormone and polycystic ovary syndrome: current status, hotspots, and trends.抗苗勒管激素与多囊卵巢综合征研究的文献计量分析:现状、热点与趋势
Front Reprod Health. 2025 Apr 24;7:1519249. doi: 10.3389/frph.2025.1519249. eCollection 2025.
2
Serum anti-mullerian hormone levels and age among Samoan women.萨摩亚女性的血清抗苗勒管激素水平与年龄
Reprod Biol Endocrinol. 2025 Mar 19;23(1):45. doi: 10.1186/s12958-025-01379-y.

本文引用的文献

1
Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study.HARMONIA研究中抗苗勒管激素临界值用于多囊卵巢形态学诊断多囊卵巢综合征的验证:一项前瞻性非干预性研究方案
JMIR Res Protoc. 2024 Feb 6;13:e48854. doi: 10.2196/48854.
2
Considerations in the Treatment of Depression and Anxiety in Women with PCOS.多囊卵巢综合征患者抑郁焦虑的治疗考虑因素。
Semin Reprod Med. 2023 Mar;41(1-02):37-44. doi: 10.1055/s-0043-1777720. Epub 2023 Dec 19.
3
Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters.
血清抗苗勒管激素(AMH)水平预测多囊卵巢综合征(PCOS)的效能及其与临床、生化和激素参数的关联。
Indian J Clin Biochem. 2023 Oct;38(4):457-465. doi: 10.1007/s12291-022-01058-4. Epub 2022 Sep 6.
4
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-2469. doi: 10.1210/clinem/dgad463.
5
AMH as part of the diagnostic PCOS workup in large epidemiological studies.抗缪勒管激素(AMH)作为大型流行病学研究中多囊卵巢综合征(PCOS)诊断检查的一部分。
Eur J Endocrinol. 2023 Jun 7;188(6):547-554. doi: 10.1093/ejendo/lvad065.
6
The diagnostic experience of polycystic ovary syndrome: A scoping review of patient perspectives.多囊卵巢综合征的诊断体验:患者观点的范围综述。
Patient Educ Couns. 2023 Aug;113:107771. doi: 10.1016/j.pec.2023.107771. Epub 2023 Apr 23.
7
Serum anti-müllerian hormone (AMH) concentration during pregnancy: a longitudinal study.孕期血清抗苗勒管激素(AMH)浓度:一项纵向研究。
Reprod Fertil. 2023 Mar 1;4(2). doi: 10.1530/RAF-22-0128.
8
The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study.抗苗勒管激素的参考值与 BMI 呈负相关,可用于诊断多囊卵巢综合征:一项回顾性研究。
Reprod Biol Endocrinol. 2023 Feb 1;21(1):15. doi: 10.1186/s12958-023-01064-y.
9
Polycystic ovary syndrome.多囊卵巢综合征。
Lancet Diabetes Endocrinol. 2022 Sep;10(9):668-680. doi: 10.1016/S2213-8587(22)00163-2. Epub 2022 Aug 4.
10
Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome.多囊卵巢综合征患者的 3 种不同 AMH 检测方法与 AMH 水平和卵泡计数的比较。
J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3714-e3722. doi: 10.1210/clinem/dgac370.